跳至主要内容
临床试验/DRKS00025428
DRKS00025428招募中未知

Pilot study on the introduction of standardized, pre-therapeutic endoscopy, possibly with marker implantation (BioXmark), in patients with esophageal cancer and primary curative therapy intention at the NCT/UCC. - EVI2

niversitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Strahlentherapie und Radioonkologie0 个研究点目标入组 10 人开始时间: 2021年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • histologically confirmed tumor
  • - Patients with cT2 N0 M0 tumors suitable for primary resection
  • - Patients with cT2-4 N+ M0 tumors suitable for neoadjuvant radiochemotherapy (40-41.4 Gy) followed by resection
  • - Patients with cT2-4 N+ M0 tumors who are eligible for primary definitive radiochemotherapy due to co-morbidities or patient preference
  • - Complete stenosis of the esophagus has been excluded.
  • - Written informed consent from the patient.

排除标准

  • - Presence of distant metastases
  • - Patients who are not suitable for curative treatment.

研究者

发起方
niversitätsklinikum Carl Gustav Carus Dresden, Klinik und Poliklinik für Strahlentherapie und Radioonkologie

相似试验